People · Operator

Menachem Goldmunz

Named in public records as an officer, director or promoter · active 2010–2015 · Other, Biotechnology

2
Companies
6
Filings
$10.9M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Ash Improvement Technology, Inc.OtherSeed$5.8M$7.5M2012
Molecular Detection, Inc.BiotechnologySeed$5.1M$154.5M2010
Operator network

Menachem Goldmunz at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Michael Cohen · 12 companies · 1 sharedMichael CohenMichael Riley · 2 companies · 1 sharedMichael RileyErnesto Schumperli · 1 companies · 1 sharedErnesto SchumperliMarc Zacharias · 1 companies · 1 sharedMarc ZachariasMorty Schaja · 1 companies · 1 sharedMorty SchajaPaul Schuler · 1 companies · 1 sharedPaul SchulerWayne Fried · 1 companies · 1 sharedWayne FriedDavid Anderson · 21 companies · 1 sharedDavid AndersonAryeh Gassel · 1 companies · 1 sharedAryeh GasselBoris Kalandar · 1 companies · 1 sharedBoris KalandarPeter Linder · 1 companies · 1 sharedPeter LinderTodd Wallach · 1 companies · 1 sharedTodd WallachVinay Chowdhry · 1 companies · 1 sharedVinay ChowdhryAsh Improvement Technology, Inc. · $5.8M raisedAsh Improvement Techn…Molecular Detection, Inc. · $5.1M raisedMolecular Detection, …Menachem GoldmunzMG
Menachem Goldmunz Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Menachem Goldmunz on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
David Anderson121
Michael Cohen112
Michael Riley12
Morty Schaja11
Marc Zacharias11
Ernesto Schumperli11
Aryeh Gassel11
Todd Wallach11
Boris Kalandar11
Vinay Chowdhry11
Peter Linder11
Wayne Fried11
Paul Schuler11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.